https://www.selleckchem.com/pr....oducts/dlin-kc2-dma.
These results suggest that inflammation-related genes and pathways may play an important role in the leukemic transformation of MDS-MF. RASopathies are a group of syndromes showing clinical overlap caused by mutations in genes affecting the RAS-MAPK pathway. Consequent disruption on cellular signaling leads and is driven by phosphoproteome remodeling. However, we still lack a comprehensive picture of the different key players and altered downstream effectors. An in silico interactome of RASopathy proteins was generated using pathwa
Like
Comment
Share
